Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

[1]  A. Teppo,et al.  Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients. , 2003, Clinical nephrology.

[2]  R. Mooney,et al.  Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.

[3]  R. Ferrell,et al.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. , 2002, Kidney international.

[4]  H. Parving,et al.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. , 2002, Diabetes.

[5]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  P. Ridker,et al.  Tumour necrosis factor-α, inflammatory biomarkers, and atherogenesis , 2002 .

[7]  C Guijarro,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[8]  A. Steensberg,et al.  Muscle‐derived interleukin‐6: possible biological effects , 2001, The Journal of physiology.

[9]  C. Wanner,et al.  Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? , 2001, Kidney international. Supplement.

[10]  J. Egido,et al.  Transcription factor-kappa B (NF-kappa B) and renal disease. , 2001, Kidney international.

[11]  S. Haffner,et al.  Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. , 2000, Kidney international.

[12]  H. Sobajima,et al.  Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy , 2000, Nephron.

[13]  T. Orchard,et al.  Can clinical factors estimate insulin resistance in type 1 diabetes? , 2000, Diabetes.

[14]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[15]  J. Palmblad,et al.  Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? , 1999, Journal of internal medicine.

[16]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[17]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[18]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[19]  P. Rossing,et al.  Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. , 1996, Thrombosis research.

[20]  P. Andersen,et al.  The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.

[21]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  A. Kok,et al.  Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation , 1999, Diabetologia.

[23]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[24]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .